Clinical Trial Update: Predicting Sites of Tumour Progression in the Invasive Margin of Glioblastomas (PRaM-GBM Study)

View source ↗

Summary

The PRaM-GBM clinical trial in glioblastoma has completed, providing an update on the study and its aim to predict sites of tumor progression in the invasive ma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Snippet

Sponsor: CCTU- Cancer Theme | Conditions: High Grade Glioma | Status: COMPLETED